Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATX-101 for submental fat reduction
NCT01294644Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Jan 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of sodium deoxycholate in submental fat, sponsored by Kythera Biopharmaceuticals. Started Jan 2011; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT01294644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294644.